Cure Pharmaceutical Holding Corp.
GPTKB entity
Properties (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Strategic acquisitions in biotech
|
| gptkbp:CEO |
Rob_Davidson
Roberto_A._C._M._de_la_Torre |
| gptkbp:collaborations |
Academic institutions
|
| gptkbp:employees |
Over 50
|
| gptkbp:financials |
Quarterly and annual reports
|
| gptkbp:focus |
Drug delivery systems
|
| gptkbp:founded |
2015
|
| gptkbp:headquarters |
gptkb:Los_Angeles,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cure Pharmaceutical Holding Corp.
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:investmentFocus |
Institutional and retail investors
|
| gptkbp:market |
Approximately $50 million
|
| gptkbp:mission |
To improve patient outcomes through innovative drug delivery.
|
| gptkbp:partnerships |
Various pharmaceutical companies
|
| gptkbp:patentCitation |
Multiple patents in drug delivery technology
|
| gptkbp:products |
Cureform
CureForm |
| gptkbp:regulatoryCompliance |
FDA_approved_products
|
| gptkbp:researchFocus |
Innovative drug formulations
|
| gptkbp:subsidiary |
Cure_Pharmaceutical,_Inc.
|
| gptkbp:tradedOn |
OTC Markets
|
| gptkbp:type |
Public company
|
| gptkbp:website |
www.curepharmaceutical.com
|